Literature DB >> 12046846

Adult bone marrow stem cells for cell and gene therapies: implications for greater use.

Christopher B Ballas1, Steven P Zielske, Stanton L Gerson.   

Abstract

There is excitement generated almost daily about the possible uses of stem cells to treat human disease. Much of the interest of late is generated by embryonic stem cells (ESCs). As exciting as ESCs may be, they are quite controversial for moral reasons, given their source. They are also scientifically controversial since they are much less well understood than the original, long-standing, and clinically successful hematopoietic stem cell (HSC). HSCs have the distinct advantage of being reasonably well characterized and have been proven in the clinic. They can be isolated by simple procedures directly from the bone marrow or from peripheral blood after being stimulated (mobilized). They can then be manipulated and delivered to a patient, often producing a cure. Their biology provides the paradigm by which all other stem cells are judged, and they have little in the way of moral controversy surrounding them given they are isolated from adults who have consented to the procedure. Another putative stem cell has gained momentum in the last few years; the mesenchymal stem cell (MSC). MSCs appear to have much in common with HSCs. They were originally characterized from bone marrow, are capable of differentiating along multiple lineages and, at least in vitro, have significant expansion capability. Unlike HSCs, they have not yet been definitively shown to function as stem cells, despite their ability to differentiate into various mesenchymal cell types under the right culture conditions. Still, there is mounting evidence these cells may be useful, if not as true stem cells then at least as vehicles for emerging cell and gene therapies, especially in the field of tissue engineering. While this is an important endpoint, it is more important to thoroughly understand stem cell biology. That understanding can then be applied toward the ultimate goal of using these cells not just for various forms of therapy, but rather as a tool to discover the mechanisms and means to bring about directed repair and regeneration of damaged or diseased tissues and organs. The excitement of HSCs and MSCs has been muted somewhat by the excitement surrounding ESCs, primarily due to the fact HSCs and MSCs are viewed as limited to specific cell types while ESCs could potentially be applied to any cell type. Recent information indicates HSCs, MSCs, and other cells in general may have more universal differentiation abilities than previously thought.

Entities:  

Mesh:

Year:  2002        PMID: 12046846     DOI: 10.1002/jcb.10127

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  20 in total

Review 1.  Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles.

Authors:  Brett Hall; Jennifer Dembinski; A Kate Sasser; Matus Studeny; Michael Andreeff; Frank Marini
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 2.  Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.

Authors:  Jakob Reiser; Xian-Yang Zhang; Charles S Hemenway; Debasis Mondal; Leena Pradhan; Vincent F La Russa
Journal:  Expert Opin Biol Ther       Date:  2005-12       Impact factor: 4.388

Review 3.  Stem cells and genetic disease.

Authors:  A Mackay-Sim; P Silburn
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 4.  Stem cell function and maintenance - ends that matter: role of telomeres and telomerase.

Authors:  Hamid Saeed; Mehwish Iqtedar
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

5.  Bladder reconstruction: The past, present and future.

Authors:  Omar M S El-Taji; Altaf Q Khattak; Syed A Hussain
Journal:  Oncol Lett       Date:  2015-04-28       Impact factor: 2.967

6.  Application of Chinese herbal medicines to revitalize adult stem cells for tissue regeneration.

Authors:  Hing-Lok Wong; Wing-sum Siu; Wai-ting Shum; Si Gao; Ping-Chung Leung; Chun-Hay Ko
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

Review 7.  Sources of stem cells for regenerative medicine.

Authors:  Jennifer Hipp; Anthony Atala
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

8.  Enhanced proliferation of bone marrow mesenchymal stem cells by co-culture with TM4 mouse Sertoli cells: involvement of the EGF/PI3K/AKT pathway.

Authors:  Huan Tian; Meijin Guo; Yingping Zhuang; Ju Chu; Siliang Zhang
Journal:  Mol Cell Biochem       Date:  2014-04-20       Impact factor: 3.396

9.  Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice.

Authors:  Alex H Chang; Matthias T Stephan; Leszek Lisowski; Michel Sadelain
Journal:  Mol Ther       Date:  2008-08-05       Impact factor: 11.454

10.  Korean mistletoe lectin regulates self-renewal of placenta-derived mesenchymal stem cells via autophagic mechanisms.

Authors:  J H Choi; S Y Lyu; H J Lee; J Jung; W B Park; G J Kim
Journal:  Cell Prolif       Date:  2012-10       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.